Kristin Harkins, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3911 Avenue B Ste 3100, Scottsbluff, NE 69361 Phone: 308-635-3033 Fax: 308-635-3010 |
Mr. Daniel Lee Rowland, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3911 Avenue B, Suite 3100, Scottsbluff, NE 69361 Phone: 308-635-3033 |
Dr. Karissa A Johnson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3911 Avenue B Ste 3100, Scottsbluff, NE 69361 Phone: 308-635-3033 Fax: 308-635-3010 |
Abigail Brubaker, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3911 Avenue B Ste 3100, Scottsbluff, NE 69361 Phone: 308-635-3033 |
Leann Renee Havener, APRN Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3911 Avenue B Ste 3100, Scottsbluff, NE 69361 Phone: 402-552-2700 Fax: 402-552-2709 |
News Archive
A new study that surveyed physicians and nurses in hospitals within cancer centers in Germany suggests that many patients there do not experience a dignified death.
Hospitals' efforts to reduce the portion of patients who are readmitted for follow-up care are proving successful in many cases, but even though the moves often result in savings for insurers, the hospitals do not necessarily benefit financially, the New York Times reports. Because insurer payments are based on treatments provided rather than the health of patients, hospitals can "actually lose money by providing better care," the Times reports.
Neuroscientists at MIT have developed a powerful new class of tools to reversibly shut down brain activity using different colors of light.
A symposium to be hosted by the Johns Hopkins Brain Science Institute (BSi) on Oct. 18 at the Baltimore Convention Center will bring together the pharmaceutical industry and academic-based research institutions with the common goal of exploring how the two can best work together to enhance and facilitate the discovery of new drugs.
A new study shows that diabetic retinopathy (DR), or retinal disease caused by the high blood glucose levels in diabetes mellitus, is due to the death of retinal cells because of the high levels of a pro-enzyme called lysyl oxidase propeptide (LOX-PP). This could help researchers develop specific treatments by targeting this molecule.
› Verified 6 days ago